Organized by the Alliance for Advanced Therapies March 12-13, 2014
The Advanced Therapies Summit 2014 is the fourth edition of this successful high-level event. This one-day meeting brings together executives from advanced therapies and biopharmaceutical companies, academic institutes, life science analysts and other organizations involved in cell therapy, regenerative medicine, gene and immuno-therapies to discuss the latest updates in the advanced therapies field.
Sessions will focus on: •The latest regulatory and policy developments across the globe. •Early lessons from companies with approved products. This session will aim to outline lessons from their commercialisation experience. •T-cell therapies. This will provide an update on the technology, clinical experiences and latest company approaches, trying to separate the hope from the hype in this very dynamic research area. •Standardisation and its role. This will examine the current status of standardisation and lessons to be learned from other sectors.
Program Agenda Dinner | Wednesday March 12, 7:30pm Advanced Therapies Summit | Thursday March 13, 8:45am – 5:30pm For more information on the program, please click here
Registration Fee: Registration fee is Euro 750 (excl. VAT) for AAT and ARM members and Euro 1,000 (excl. VAT) for non members. AAT/ARM Discount: AAT and ARM members receive a Euro 250 discount.
Location: Hotel NH Lingotto Tech, Via Nizza, 230. 10126 Turin, Italy
Hotel Accommodation: Single/Double: Euro 179/199 inclusive of breakfast, excl. VAT. Reservations are made on a first-come, first-served basis. To book your hotel room, please contact: Marie Mahieux on +32 2 740 22 38 or firstname.lastname@example.org.
About AAT The Alliance for Advanced Therapies (AAT) promotes the interests of the advanced therapies sector in Europe. The Alliance represents companies, academic institutes and other organizations involved in cell therapy, regenerative medicine, gene therapy and other potentially life-saving advanced therapeutics. The AAT provides a credible voice for the sector and offers members a valuable worldwide network within advanced therapies.